Eczema & Psychiatric Disorders: Bidirectional Links Discovered in Genetic Analysis (2024)

TLDR: A recent study explored the potential causal relationship between atopic dermatitis (AD) a.k.a. eczema and various psychiatric disorders – finding bidirectional links.

Highlights:

  • Data from over 860,000 individuals were analyzed
  • Atopic dermatitis (eczema) increased risk of ADHD & ASD
  • ADHD, anorexia nervosa (AN), bipolar disorder (BD) increased the risk of developing atopic dermatitis (eczema)
  • Findings were independent of biases from heterogeneity and horizontal plietropy

Source: BMC Psychiatry (2024)

Eczema & Psychiatric Disorders: Preexisting Links

Atopic dermatitis (AD), commonly known as eczema, is a chronic inflammatory skin condition characterized by itchy, red, and swollen skin.

  • It is one of the most prevalent skin diseases, affecting millions of individuals worldwide.
  • Eczema typically manifests in early childhood, but it can persist or recur throughout life.

The etiology of eczema is complex and multifactorial, involving a combination of genetic predisposition, environmental factors, immune system dysregulation, and skin barrier defects.

Key contributors:

  • Genetic Factors: Family history of AD, asthma, or hay fever increases the risk of developing the condition.
  • Environmental Triggers: Allergens, irritants, climate, and infections can exacerbate symptoms.
  • Immune Dysregulation: An imbalance in the immune system, particularly an overactive response, leads to inflammation and skin barrier dysfunction.
  • Skin Barrier Defects: Mutations in the filaggrin gene, which is crucial for skin barrier function, can contribute to the development of eczema.

Link to Psychiatric Disorders: Eczema has been frequently associated with various psychiatric disorders, including anxiety, depression, and attention deficit hyperactivity disorder (ADHD).

Several potential mechanisms might explain the relationship between eczema and psychiatric conditions:

  • Chronic Inflammation: Chronic skin inflammation in eczema can lead to systemic inflammation, affecting the brain and contributing to psychiatric symptoms. Pro-inflammatory cytokines like interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) can disrupt neural pathways and mood regulation.
  • Neuroimmune Interactions: The skin and nervous system are closely linked through neuroimmune mechanisms. Psychological stress can exacerbate eczema symptoms by triggering neuropeptides and stress hormones that affect the skin’s immune response. Mast cells, involved in eczema’s pathogenesis, can release neuroactive substances that impact brain function and behavior.
  • Sleep Disturbances: Intense itching and discomfort in eczema patients often lead to sleep disturbances, which are closely linked to the development and exacerbation of psychiatric disorders.
  • Quality of Life & Social Stigma: The visible symptoms of eczema can lead to social stigma, reduced quality of life, and social isolation, contributing to anxiety, depression, and other mental health issues.

New Study: Eczema vs. Psychiatric Disorders Risk (2024)

Researchers evaluated whether eczema (atopic dermatitis) influences the risk of developing psychiatric conditions such as:

Autism spectrum disorder (ASD), major depressive disorder (MDD), attention deficit hyperactivity disorder (ADHD), bipolar disorder (BD), anorexia nervosa (AN), Tourette syndrome (TS), schizophrenia, and anxiety, and vice versa.

Methods

The study employed a bidirectional two-sample Mendelian randomization (MR) approach, leveraging genetic data to infer causality.

1. Data Sources

Atopic Dermatitis: Summary statistics from the largest genome-wide association studies (GWAS) on eczema, involving 60,653 cases and 804,329 controls of European ancestry.

Psychiatric Disorders: Data from the Psychiatric Genomics Consortium and other public databases, covering a range of psychiatric conditions with sample sizes varying from 3,833 to 173,005 individuals.

2. Mendelian Randomization Analysis

Multiple MR methods were used, including the inverse variance weighted (IVW) method, MR-Egger regression, weighted median method, simple mode method, and weighted mode method, to ensure robustness and minimize bias.

Instrumental variables (IVs) were selected based on SNPs significantly associated with the exposures at a genome-wide significance level (P < 1e-05).

Weak IVs and those confounded by factors like biological sex, age, obesity, and other diseases were excluded to meet the MR assumptions.

3. Sensitivity Analysis

Various sensitivity analyses were conducted to check for horizontal pleiotropy and heterogeneity, including MR-Egger intercept tests, Cochran’s Q test, IVW outlier methods, and leave-one-out analyses.

What were the findings?

The bidirectional MR analysis revealed several significant causal relationships:

1. Eczema Increased the Risk of Psychiatric Disorders

  • ADHD: AD was associated with an increased risk of ADHD (OR = 1.116; 95% CI: [1.009, 1.234]; P = 0.033).
  • Autism: AD was also linked to a higher risk of ASD (OR = 1.131; 95% CI: [1.023, 1.251]; P = 0.016).

2. Psychiatric Disorders Increasing the Risk of Eczema

  • ADHD: ADHD was associated with an increased risk of developing AD (OR = 1.112; 95% CI: [1.094, 1.130]; P = 9.20e-40).
  • Anorexia: Anorexia nervosa was linked to a higher risk of AD (OR = 1.1; 95% CI: [1.068, 1.134]; P = 4.45e-10).
  • Bipolar Disorder: Bipolar disorder was associated with an increased risk of AD (OR = 1.067; 95% CI: [1.009, 1.128]; P = 0.023).

3. Robustness of Findings

The causal associations were robust and not affected by biases from heterogeneity and horizontal pleiotropy.

See also  NSI-189 for Depression & Cognitive Enhancement via Neurogenesis & BDNF

Only the causal relationship between eczema and ASD was independent of reverse effect bias.

Limitations

  • Population Specificity: The findings are based on data from individuals of European ancestry, which may limit the generalizability to other populations.
  • Data Source Limitations: The reliance on summary statistics from GWAS means the analysis cannot account for potential confounding variables not captured in the genetic data.
  • Bidirectionality Complexity: While the study employed bidirectional analysis, establishing temporal causality in complex traits like AD and psychiatric disorders remains challenging.

Major Findings in Detail: Eczema & Mental Disorders (Causal Relationships)

The study uncovered significant causal relationships between atopic dermatitis (AD) and several psychiatric disorders.

1. Eczema Increasing the Risk of Psychiatric Disorders

ADHD

Causal Relationship: The analysis revealed that eczema significantly increases the risk of developing attention deficit hyperactivity disorder (ADHD).

Statistical Evidence: Using the inverse variance weighted (IVW) method, the odds ratio (OR) was found to be 1.116 (95% CI: [1.009, 1.234]; P = 0.033). This was further supported by the MR-Egger regression method, which yielded an OR of 1.642 (95% CI: [1.132, 2.382]; P = 0.003).

Mechanisms: Chronic inflammation and immune dysregulation in eczema could affect neural development and function, contributing to ADHD symptoms. Pro-inflammatory cytokines may disrupt neural pathways critical for attention and behavior regulation.

Autism

Causal Relationship: The study found a significant causal link between eczema and an increased risk of autism spectrum disorder (ASD).

Statistical Evidence: The IVW method showed an OR of 1.131 (95% CI: [1.023, 1.251]; P = 0.016), while the weighted median method confirmed a similar effect (OR = 1.178; 95% CI: [1.020, 1.362]; P = 0.026).

Mechanisms: Neuroinflammation from eczema could interfere with brain development, contributing to ASD. Additionally, the disruption of the blood-brain barrier by inflammatory cytokines and mast cell activation could play a role.

2. Psychiatric Disorders Increasing the Risk of Eczema

ADHD

Causal Relationship: ADHD was identified as a risk factor for developing AD.

Statistical Evidence: The IVW method indicated an OR of 1.112 (95% CI: [1.094, 1.130]; P = 9.20e-40), with all other MR methods (weighted median, simple mode, weighted mode, and cML-MA) affirming this causal effect.

Mechanisms: The hyperactivity and impulsivity associated with ADHD may lead to behaviors that exacerbate eczema symptoms, such as scratching and poor skin care routines.

Anorexia Nervosa (AN)

Causal Relationship: Anorexia nervosa (AN) was found to increase the risk of eczema.

Statistical Evidence: The IVW method yielded an OR of 1.1 (95% CI: [1.068, 1.134]; P = 4.45e-10). Other MR methods supported this finding, except for MR-Egger.

Mechanisms: Nutritional deficiencies and altered immune responses in anorexia can weaken the skin barrier, making individuals more susceptible to eczema.

Bipolar Disorder (BD)

Causal Relationship: Bipolar disorder (BD) was associated with an increased risk of developing eczema.

Statistical Evidence: The IVW method showed an OR of 1.067 (95% CI: [1.009, 1.128]; P = 0.023). The cML-MA method also supported this causal relationship (P = 0.024).

Mechanisms: The emotional and psychological stress associated with BD could trigger or worsen eczema symptoms. Additionally, mood stabilizers and other medications used to treat BD might have side effects that impact skin health.

How might these findings be useful? (Eczema & mental health)

The study’s findings on the bidirectional causal relationships between atopic dermatitis (AD) and psychiatric disorders have significant implications and applications across various domains, including clinical practice, public health, and future research.

1. Enhanced Screening & Diagnosis

Early Identification: Healthcare providers should incorporate screening for psychiatric disorders in patients diagnosed with eczema, particularly ADHD and ASD, to facilitate early identification and intervention.

Comprehensive Assessments: Similarly, individuals diagnosed with psychiatric disorders such as ADHD, anorexia, and bipolar disorder should be evaluated for symptoms of eczema to ensure timely diagnosis and management.

2. Integrated Treatment Approaches

Holistic Care: Developing integrated treatment plans that address both dermatological and psychiatric symptoms can improve patient outcomes. For instance, combining dermatological treatments with behavioral therapy or psychiatric medications may provide comprehensive care.

Personalized Medicine: Recognizing the genetic links between eczema and psychiatric disorders can lead to personalized treatment strategies tailored to the individual’s genetic and clinical profile.

Takeaway: Eczema (Atopic Dermatitis) & Psychiatric Conditions

The study’s findings highlight the significant bidirectional causal relationships between atopic dermatitis and various psychiatric disorders.

These findings underscore the importance of integrated health approaches, early screening, and personalized treatment strategies.

By recognizing and addressing the interconnected nature of psychiatric disorders and eczema, healthcare providers may be able to improve patient outcomes and enhance the overall quality of care.

References